Issue Date | Title | Author(s) |
2017-12-04 | A microsatellite repeat in PCA3 long non-coding RNA is associated with prostate cancer risk and aggressiveness. | Lai, J; Moya, L; An, J; Hoffman, A; Srinivasan, S; Panchadsaram, J; Walpole, C; Perry-Keene, JL; Chambers, S; Australian Prostate Cancer BioResource,; Lehman, ML; Nelson, CC; Clements, JA; Batra, J |
2018 | Development of Indicators to Assess Quality of Care for Prostate Cancer | Nag, N; Millar, J; Davis, ID; Costello, S; Duthie, JB; Mark, S; Delprado, W; Smith, D; Pryor, D; Galvin, D; Sullivan, F; Murphy, Á; Roder, D; Elsaleh, H; Currow, D; White, C; Skala, M; Moretti, KL; Walker, T; De Ieso, P; Brooks, A; Heathcote, P; Frydenberg, M; Thavaseelan, J; Evans, SM |
2016-02 | Improving psychosocial health in men with prostate cancer through an intervention that reinforces masculine values - exercise. | Cormie, P; Oliffe, JL; Wootten, AC; Galvão, DA; Newton, RU; Chambers, SK |
2016-03 | Health-Related Quality of Life, Psychological Distress, and Sexual Changes Following Prostate Cancer: A Comparison of Gay and Bisexual Men with Heterosexual Men. | Ussher, JM; Perz, J; Kellett, A; Chambers, S; Latini, D; Davis, ID; Rose, D; Dowsett, GW; Williams, S |
2016-12 | The role of mindfulness in distress and quality of life for men with advanced prostate cancer. | Chambers, SK; Foley, E; Clutton, S; McDowall, R; Occhipinti, S; Berry, M; Stockler, MR; Lepore, SJ; Frydenberg, M; Gardiner, RA; Davis, ID; Smith, DP |
2016-09 | Impact of a brief exercise program on the physical and psychosocial health of prostate cancer survivors: A pilot study. | Skinner, TL; Peeters, GG; Croci, I; Bell, KR; Burton, NW; Chambers, SK; Bolam, KA |
2016-09 | Can atorvastatin with metformin change the natural history of prostate cancer as characterized by molecular, metabolomic, imaging and pathological variables? A randomized controlled trial protocol. | Roberts, MJ; Yaxley, JW; Coughlin, GD; Gianduzzo, TRJ; Esler, RC; Dunglison, NT; Chambers, SK; Medcraft, RJ; Chow, CWK; Schirra, HJ; Richards, RS; Kienzle, N; Lu, M; Brereton, I; Samaratunga, H; Perry-Keene, J; Payton, D; Oyama, C; Doi, SA; Lavin, MF; Gardiner, RA |
2017-07 | [Cost effectiveness of GnRH antagonists in patients with prostate cancer and cardiovascular risk : Comparative analysis against Leuprorelin by the Number Needed to Treat]. | Anderson, D; Lehmann, J; Ecker, T; Vosgerau, S; Donatz, V |
2017-03 | Fish-Derived Omega-3 Fatty Acids and Prostate Cancer: A Systematic Review. | Aucoin, M; Cooley, K; Knee, C; Fritz, H; Balneaves, LG; Breau, R; Fergusson, D; Skidmore, B; Wong, R; Seely, D |
2017-03 | Men's help-seeking in the first year after diagnosis of localised prostate cancer. | Hyde, MK; Newton, RU; Galvão, DA; Gardiner, RA; Occhipinti, S; Lowe, A; Wittert, GA; Chambers, SK |